Are you a journalist? Please sign up here for our press releases
Subscribe to our monthly newsletter:
Dvora Teitelbaum
10.10.2010
from the institute to Teva Pharmaceuticals Ltd.
10.10.2007
Israeli scientists identify: Genes that Affect Responses of Multiple Sclerosis Patients to Copaxone®
...
01.05.1997
Nearly three decades after a surprising discovery, Copaxone® gets FDA approval for the treatment of MS
28.01.1997
REHOVOT, Israel -- January 28, 1997 -- This week, two scientists from Israel's Weizmann Institute were honored for an...
